This issue of Surgical Oncology Clinics of North America, guest edited by Dr. James Howe, is devoted to Management of GI and Pancreatic Neuroendocrine Tumors. Dr. Howe has assembled expert authors to review the following topics: Introduction and History of GI and Pancreatic Neuroendocrine Tumors (GEPNETs); Surgical Management of Colorectal Neuroendocrine Tumors; Management of Metastatic GEPNETs; Pathologic considerations in GEPNETs; Medical Management of GEPNETs; Workup of GEPNETs; Peptide Radioreceptor Therapy (PRRT); Surgical Management of Small Bowel Neuroendocrine Tumors; The Role of Functional Imaging in GEPNETs; Surgical Management of Pancreatic Neuroendocrine Tumors; Surgical Management of Other Gastric and Duodenal Neuroendocrine Tumors; and more!

This issue of Surgical Oncology Clinics of North America, edited by Adam Berger, is devoted to Melanoma. Articles in this issue include: Current Staging and Prognostic Factors in Melanoma; Melanoma Pathology; Surgical Treatment of Primary and Recurrent Melanoma; Sentinel Lymph Node Mapping and Its Importance for Melanoma in the 21st Century; Lymph Node Dissection for Stage 3 Melanoma; Metastasectomy for Stage IV Melanoma; Local/Injectional Therapies for Satellite and In-Transit Disease; Regional Therapies for In-Transit Disease; Role for Radiation Therapy in Melanoma; Update on Immunotherapy for Melanoma; Targeted Therapies in Melanoma; and Evidence for Long-Term Follow-up of Melanoma Patients.

This issue of Surgical Oncology Clinics, Guest Edited by Dr. Jeffrey Gershenwald, presents various articles on the subject of Melanoma. Articles include: Pathologic Evaluation of the Primary Tumor and Sentinel Lymph Nodes; Staging and Prognosis; Management of Primary Melanoma; Management of the Clinically Uninvolved Nodal Basin in Cutaneous Melanoma; Evidence-based Approach to Imaging and Follow-up Guidelines for the Melanoma Patient; Treatment Strategies for the Intransit Melanoma Metastasis; Adjuvant Therapy for Stage III Melanoma; Role of Radiotherapy; Targeted Therapy; Immunotherapy; Assessment of Melanoma-specific Patient Reported Outcomes (PRO); and Metastasectomy for Stage IV Melanoma.

This issue of Surgical Oncology Clinics of North America, edited by Adam Berger, is devoted to Melanoma. Articles in this issue include: Current Staging and Prognostic Factors in Melanoma; Melanoma Pathology; Surgical Treatment of Primary and Recurrent Melanoma; Sentinel Lymph Node Mapping and Its Importance for Melanoma in the 21st Century; Lymph Node Dissection for Stage 3 Melanoma; Metastasectomy for Stage IV Melanoma; Local/Injectional Therapies for Satellite and In-Transit Disease; Regional Therapies for In-Transit Disease; Role for Radiation Therapy in Melanoma; Update on Immunotherapy for Melanoma; Targeted Therapies in Melanoma; and Evidence for Long-Term Follow-up of Melanoma Patients.

Editors Kimberly Brown and Celia Chao and authors review the latest in Melanoma. Articles will include Epidemiology, Risk Factors, Prevention, and Early Detection; Work-up and Staging of Malignant Melanoma; Principles of Surgical Treatment of Malignant Melanoma; Surviving Cutaneous Melanoma; Locoregional Therapies; Melanoma Vaccines; The Role of Radiation Therapy in Melanoma; Systemic Therapy in Melanoma; Unusual Presentations of Melanoma; Surgical Treatment Options for Stage IV Melanoma; Head and Neck Melanoma; Melanoma in Non-Caucasian Populations and more!

This issue of the Surgical Oncology Clinics will review the important clinical trials from the past eight years in following topics: breast cancer, soft tissue sarcoma, rectal and anal carcinoma, pancreatic adenocarcinoma, hepatocellular carcinoma, gastric cancer, esophageal cancer, colon cancer, advanced and metastatic colorectal carcinoma, gastrointestinal stromal tumors, and melanoma.

This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!